During the past decade, Summa Health Medina Medical Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 9 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summa Health Medina Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Radiation Therapy Oncology Group" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "NRG Oncology" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summa Health Medina Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Biologics, Inc." with 1 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Summa Health Medina Medical Center" are "Invasive Breast Carcinoma" (3 trials), "Prostate Cancer" (3 trials), "Cervical Cancer" (2 trials), "Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8" (2 trials) and "HER2-Positive Breast Carcinoma" (2 trials). Many other conditions were trialed in "Summa Health Medina Medical Center" in a lesser frequency.

Most popular intervention types in "Summa Health Medina Medical Center" are "Drug" (24 trials), "Radiation" (21 trials), "Other" (19 trials), "Biological" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (12 trials), "Laboratory Biomarker Analysis" (7 trials), "Cisplatin" (6 trials), "Intensity-Modulated Radiation Therapy" (6 trials) and "Questionnaire Administration" (6 trials). Other intervention names were less common.

The vast majority of trials in "Summa Health Medina Medical Center" are 18 trials for "All" genders, 8 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Summa Health Medina Medical Center". undefined are not yet recruiting, 9 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Summa Health Medina Medical Center, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Summa Health Medina Medical Center, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".